IL-17A inhibitor-induced leucocytoclastic vasculitis is responsive to IL-23 blockade in a psoriatic arthritis patient.

Binod, K C; Jabbour, Austin; Poudel, Pooja; Banki, Katalin; Perl, Andras

Binod, K C; Jabbour, Austin; Poudel, Pooja; Banki, Katalin; Perl, Andras.

Afiliação

Binod KC; SUNY Upstate Medical University, Syracuse, New York, USA.
Jabbour A; SUNY Upstate Medical University Hospital, Syracuse, New York, USA.
Poudel P; SUNY Upstate Medical University, Syracuse, New York, USA.
Banki K; Pathology, SUNY Upstate Medical University Norton College of Medicine, Syracuse, New York, USA.
Perl A; Medicine, SUNY Upstate Medical University Norton College of Medicine, Syracuse, New York, USA PERLA@upstate.edu.

Ann Rheum Dis ; 83(2): 265-267, 2024 Jan 11.

Article em En | MEDLINE | ID: mdl-37679036

Assuntos

Artrite Psoriásica; Psoríase; Vasculite Leucocitoclástica Cutânea; Humanos; Artrite Psoriásica/tratamento farmacológico; Interleucina-17; Anticorpos Monoclonais Humanizados/farmacologia; Vasculite Leucocitoclástica Cutânea/induzido quimicamente; Interleucina-23

Palavras-chave

Antirheumatic Agents; Biological Therapy; Psoriatic Arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Artrite Psoriásica / Vasculite Leucocitoclástica Cutânea Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google